A Study to Evaluate a Single Intravenous Dose of Motavizumab for the Treatment of Children Hospitalized With Respiratory Syncytial Virus (RSV) Illness
Public ClinicalTrials.gov record NCT00421304. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate a Single Intravenous Dose of Motavizumab (MEDI-524), a Humanized Enhanced Potency Monoclonal Antibody Against Respiratory Syncytial Virus (RSV), for the Treatment of Children Hospitalized With RSV Illness
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of this study is to describe the effect of a single dose of medication compared to placebo in the upper respiratory tract in previously healthy children less than or equal to 12 months of age who are hospitalized with lower respiratory tract illness.
Study identification
- NCT ID
- NCT00421304
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 118 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 0 Months to 12 Months
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 10, 2007 (Actual)
- Primary completion
- Sep 17, 2009 (Actual)
- Completion
- Sep 17, 2009 (Actual)
- Last update posted
- Aug 27, 2021
2007 – 2009
United States locations
- U.S. sites
- 26
- U.S. states
- 17
- U.S. cities
- 26
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Tucson | Arizona | 85724 | — |
| Research Site | Long Beach | California | 90806 | — |
| Research Site | Orange | California | 92868 | — |
| Research Site | San Diego | California | 92123 | — |
| Research Site | Jacksonville | Florida | — | — |
| Research Site | Honolulu | Hawaii | 96826 | — |
| Research Site | Chicago | Illinois | 60612 | — |
| Research Site | Oak Lawn | Illinois | 60453 | — |
| Research Site | Boston | Massachusetts | 02111 | — |
| Research Site | Jackson | Mississippi | 39216-4505 | — |
| Research Site | Omaha | Nebraska | 68198 | — |
| Research Site | Brooklyn | New York | 11201 | — |
| Research Site | Buffalo | New York | 14222 | — |
| Research Site | Mineola | New York | 11501 | — |
| Research Site | New Hyde Park | New York | 11040 | — |
| Research Site | Rochester | New York | 14642 | — |
| Research Site | Syracuse | New York | 13210 | — |
| Research Site | Columbus | Ohio | 43205 | — |
| Research Site | Oklahoma City | Oklahoma | 73104-5066 | — |
| Research Site | Portland | Oregon | 97239 | — |
| Research Site | Dallas | Texas | 75390 | — |
| Research Site | Houston | Texas | 77030 | — |
| Research Site | Salt Lake City | Utah | 84108 | — |
| Research Site | Seattle | Washington | 98105 | — |
| Research Site | Morgantown | West Virginia | 26506 | — |
| Research Site | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 9 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00421304, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 27, 2021 · Synced Oct 27, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00421304 live on ClinicalTrials.gov.